In a report released today, Eric Hagen from BTIG maintained a Buy rating on Dynex Capital (DX – Research Report), with a price target of ...

BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $622 from $561 and keeps a Buy rating on the shares after ...

BTIG analyst Julian Harrison maintained a Hold rating on United Therapeutics (UTHR – Research Report) on January 21. The company’s shares ...

Here are our top real estate investment trust (REIT) ideas for 2025. They pay among the highest yields and offer solid growth ...

Tuesday, shares of Ideaya Biosciences (NASDAQ:IDYA), trading at $22.18 near its 52-week low of $22.10, drew attention as BTIG analysts maintained their Buy rating and $62.00 price target.

BTIG analyst Maria Thibault revised the price target for Outset Medical (TASE:PMCN) Inc. (NASDAQ:OM) to $3.00, a decrease ...

Tuesday, shares of Ideaya Biosciences (NASDAQ:IDYA), trading at $22.18 near its 52-week low of $22.10, drew attention as BTIG analysts maintained their Buy rating and $62.00 price target. According to ...

Intuitive Surgical (NASDAQ:ISRG) shares maintained their Buy rating and a $561.00 price target from BTIG, despite potential ...

Experts say the Trump administration is waiting for Scott Bessent to be confirmed as treasury secretary and for other ...

Tripadvisor reached out to 19 parties and financial sponsors starting in December 2023 when it began considering strategic ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.65% of ...